One of the Nation's Leading Analytical Testing Laboratories is Now Easier to Access -- Pace Analytical Launches New Web Site to Showcase Its Three Business Divisions

Pace Analytical Services, Inc. Is Pleased To Announce The Launch Of Its New And Improved Website. The New Site Provides Users With A Comprehensive Overview Of Pace Analytical And Incorporates A More User-Friendly Design Layout To Enhance Functionality And Navigation. The Site Also Offers An Expan...

Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections

ASHBURN, Va., June 18 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced positive provisional findings from its three phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN TOPICAL for the...

Next Stage Solutions Announces Three New Financial Services For Emerging Business

Next Stage Solutions, Inc. has expanded its financial services offerings to further meet the needs of emerging businesses. Specifically, Next Stage Solutions (NSS) has launched three new services: First, CFO on Demand - NSS partners with their clients acting as an outsourced CFO on an as-needed ...

Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting

SEATTLE, WA, May 30 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) (TSX:ONY) (the "Company") today announced that data from clinical trials for three of the Company's product candidates were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on May 30, 2009 i...

Trubion Announces Acceptance of Three Presentations on Its TRU-016 Product Candidate at the 2009 ASCO Annual Meeting

Phase 1: Encouraging Results Observed in CLL Patients Treated With Low Doses of TRU-016 Preclinical Efficacy: TRU-016 is Additive or Synergistic in Combination with Established Therapeutics Preclinical Mechanism Apoptosis in CLL Cells Occurs Via Distinct Mechanism Compared With Other Th...

REG Signs Agreement with Three Biodiesel Plants to Consolidate

Biodiesel industry leader to acquire 105 MGY of additional capacity in Iowa and Illinois to meet diesel market demand. Ames, Iowa (Vocus) May 12, 2009 -- Renewable Energy Group® today announced it has entered into agreements to consolidate with three commercial-scal...

Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver

CAMBRIDGE, Mass., April 23 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported data from its three hepatitis C development programs being pr...

WuXi AppTec Welcomes Three Senior Professionals

SHANGHAI, March 24 /PRNewswire-Asia/ -- WuXi AppTec (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced the addition of three key senior professionals. (Log...

Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)

CAMBRIDGE, Mass., March 18 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that four abstracts from the company's hepatitis C antiviral...

Osteotech Reports Fourth Quarter and Full Year 2008 Financial Results; Company Plans Three Product Launches and Unveilings in 2009; Will Provide 2009 Guidance During Conference Call on March 5, 2009 at 9:00 a.m. EST

EATONTOWN, N.J., March 4 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE ), a leader in the emerging field of biologic products for regenerative healing, today reported financial results for the fourth quarter and full year ended December 31, 2008. "The last twelve months were an im...

Savara Expands Board of Directors, Appoints Three New Members

Nevan Elam, Former Head of Nektar Therapeutic's Pulmonary Business Unit, Among New Board of Directors Members AUSTIN, Texas, March 4 /PRNewswire/ -- Savara, Inc., a biopharmaceutical company developing novel respiratory therapeutics utilizing its NanoCluster dry-powder formulation tech...

GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years

ST. JOSEPH, Mich., Jan. 6 /PRNewswire/ -- GeneGo, Inc., a leading provider of software and high quality manually curated databases for systems biology and pathway analysis , today announced that Bayer Schering Pharma AG has renewed its MetaCore licenses for another three years. Bayer Scherin...

BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition

BIRMINGHAM, Ala., Dec. 5 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals (Nasdaq: BCRX ) announced today that the Company will present pre-clinical data on Forodesine HCl and BCX-4208, and clinical data on BCX-4208 at the 50th American Society of Hematology (ASH) Annual Meeting and Exposition...

LI-COR Introduces Three IRDye(R) Near-Infrared Fluorescence Resonance Energy Transfer (NIR-FRET) Protease Substrates

LINCOLN, Neb., Nov. 12 /PRNewswire/ -- Protease substrates provide a sensitive method to detect protease activity, measure potency of inhibitors and screen compound collections for discovery of drug candidates. LI-COR Biosciences now offers three different IRDye NIR-FRET Protease Substrates: I...

ViroPharma to Present at Three November Healthcare Conferences

EXTON, Pa., Nov. 6 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the Rodman & Renshaw Annual Global Investment Conference at 12:25 P.M. ET on Wednesday, November 12, 2...

Gable PR Honored by PRSA San Diego Chapter with Three Awards for Client Programs

PRSA San Diego honored Gable PR with one Silver Bernays Mark of Merit award, for superior execution in a global communications campaign for the Biotechnology Industry Organization's (BIO) 2008 BIO International Convention. The agency also received two Bronze Bernays Mark of Merit awards for the ...

NicOx Reports Results for the First Three Quarters of 2008

SOPHIA ANTIPOLIS, France, October 22 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today reported financial results for the nine months ended September 30, 2008. Key highlights of the third quarter of 2008: - Positive top-line results from the 302 study for naproxcinod. The...

Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years

Zero Incidence of Late Stent Thrombosis Reported in CUSTOM I, II, and III Trials WASHINGTON and MENLO PARK, Calif., Oct. 13 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT ) today announced positive long-term follow-up data from the CUSTOM I, II and III clin...

Cell Therapeutics, Inc. (CTI) to Present at Three Upcoming Investor Conferences

SEATTLE, Oct. 13 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) has been selected to present at three upcoming investor conferences. The conferences include the 7th Annual BIO Investor Forum in San Francisco in October, the 19th Annual Oppenheimer & Co. Healthca...

ViroPharma to Present at Three October Healthcare Conferences

EXTON, Pa., Oct. 1 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the third annual JMP Securities Healthcare Focus Conference at 2:30 P.M. ET on Monday, October 6, 2008...

TorreyPines Therapeutics Strategically Repositions as Development Company Focusing on Three Versatile Lead Compounds

- Plan Includes Shut Down of Discovery Operations and Expansion of Business Development Activities - LA JOLLA, Calif., Sept. 25 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced that it will transition from a discovery and development company ...

Spherics, Inc. Presented Three Key Technologies (BIOROD(TM), BIOGIT(TM), and SPHEROMER(TM)) at the 35th Annual Meeting of Controlled Release Society

WELLESLEY HILLS, Mass., Sept. 22 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee of the assets of Spherics, Inc. ("Spherics") for the benefit of creditors, announced today that all oral drug delivery intellectual property will be sold at a sealed bid auction on October 10, 2008....

ViroPharma to Present at Three September Healthcare Conferences

EXTON, Pa., Aug. 28 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the Thomas Weisel Partners 2008 Healthcare Conference at 8:00 A.M. ET on Thursday, September 4, 2008....

Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School

Parents of students with known allergies are urged to put auto-injectable epinephrine at the top of the school supplies list SILVER SPRING, Md., Aug. 27 /PRNewswire/ -- A new survey conducted by the National Association of School Nurses (NASN) found that 72% of school nurses have stud...

American Laser Centers Opens Three Minneapolis-St. Paul Area Clinics

Laser hair removal, skin rejuvenation, VelaShape and three new clinics available to Minneapolis area beauty seekers MINNEAPOLIS, Aug. 8 /PRNewswire/ -- American Laser Centers, http://www.americanlaser.com, the largest provider of laser hair removal and other noninvasive aesthet...

FDA Extends Review Timeline for Ustekinumab Biologic License Application Three Months

HORSHAM, Pa., Aug. 8 /PRNewswire/ -- Centocor, Inc., today announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline for the Biologic License Application for ustekinumab, a subcutaneous biologic therapy, by three months to December 2008. The application, filed...

SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008

SAN DIEGO, Aug. 7 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals (Nasdaq: SGXP ) today announced its financial results for the three and six months ended June 30, 2008. For the three months ended June 30, 2008, the Company posted revenues of $4.3 million and a net loss of $7.2 million. For the...

China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors

TAI'AN, Shandong, China, July 30 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that, effective July 24, 200...

Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development

New Development Programs to Include Response Prediction to Ovarian Cancer Treatment, Predicting Risk of Gastric Cancer Recurrence, and Differentiation of Small Cell From Non-Small Cell Lung Cancer In Addition, the Company has Identified Unique microRNA Biomarkers in the Serum of Colon ...

Biomoda Appoints Three Business Leaders to Board of Directors

New members will help commercialize innovative technologies for early lung cancer detection ALBUQUERQUE, N.M., May 5 /PRNewswire-FirstCall/ -- Biomoda, Inc. (OTC Bulletin Board: BMOD) ( http://www.biomoda.com ), a development stage medical diagnostics company, today a...

Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2008

SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's Presi...

JIC Invests in Three New Alternative Energy Projects

Major First Step to Tap Alternative Energy Business in China HONG KONG, April 22 /Xinhua-PRNewswire-FirstCall/ -- J.I.C. Technology Company Ltd ("JIC" or "the Company") to be renamed as Hong Kong Energy Holdings Limited ("HKE") (HKEx: 987), a wholly-owned subsidiary of HKC (Holdings) Lim...

Startech Environmental to Have Three Plasma Converters in Former Pharmaceutical Industry Facility in Puerto Rico

WILTON, Conn., April 21 /PRNewswire-FirstCall/ -- Startech Environmental Corp. (OTC Bulletin Board: STHK), a fully reporting, Award-winning Environment and Energy Company, announced today that the EnviroSafe Industrial Services Corporation of San Juan, Puerto Rico has expanded its original pla...

Bluestar Silicones Introduces Three New Soft and Durable Liquid Silicone Rubber Products

EAST BRUNSWICK, N.J., April 7, 2008 /PRNewswire/ -- Bluestar Silicones introduces a new range of Silbione(R) brand soft liquid silicone rubber (LSR) products for the healthcare market that provide a unique combination of strong physical properties and trouble-free processing at 05-, 10- and 25...

Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord

Projects have vast potential to help scientists worldwide gain new insight into neurological diseases and disorders Institute seeks funding support for human brain, spinal cord and developing brain projects SEATTLE, March 13 /PRNewswire/ -- The Allen I...

Tianyin Pharmaceutical Appoints Three New Independent Board Members

Additions Bring Experience and Expertise in the Chinese Pharmaceutical Industry, International Business Operations and Finance CHENGDU, China, March 4 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (OTC Bulletin Board: VSCO), a manufacturer and supplier of moderniz...

Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business

Approvals include CONFIENT(TM) ICD, LIVIAN(TM) CRT-D and upgraded LATITUDE(R) Patient Management System NATICK, Mass., Feb. 25 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced U.S. Food and Drug Administration (FDA) approval for three pro...

China Pharma Appoints Three Independent Non-Executive Directors

- Three New Board Members to Form Audit Committee NEW YORK and HAIKOU, China, Feb. 5 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and brand bio-pharmaceutical products in Ch...

Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections

- Activity data on lead NNRTI, RDEA806, and next generation compounds to be discussed - CARLSBAD, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ) today announced that preclinical data on the Company's non-nucleoside reverse transcri...

Icahn Confirms Intention to Nominate Three Directors at Biogen

NEW YORK, Jan. 28 /PRNewswire/ -- Carl Icahn confirmed today that entities affiliated with him have given notice to Biogen Idec that they intend to nominate three persons at Biogen's forthcoming 2008 Annual Meeting of Stockholders to serve as directors of Biogen. Biogen currently has a stagger...